95 related articles for article (PubMed ID: 29125105)
1. Sequence Analysis and Comparison of the Key Genes of Domestic Live Attenuated Varicella Vaccine.
Quan YR; Chen Z; Qiu P; Cui XY; Li CG; Yuan LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):637-642. PubMed ID: 29125105
[TBL] [Abstract][Full Text] [Related]
2. Complete DNA sequences of two oka strain varicella-zoster virus genomes.
Tillieux SL; Halsey WS; Thomas ES; Voycik JJ; Sathe GM; Vassilev V
J Virol; 2008 Nov; 82(22):11023-44. PubMed ID: 18787000
[TBL] [Abstract][Full Text] [Related]
3. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.
Quinlivan ML; Jensen NJ; Radford KW; Schmid DS
J Clin Microbiol; 2012 May; 50(5):1533-8. PubMed ID: 22378912
[TBL] [Abstract][Full Text] [Related]
4. [Characterization analysis of gM, gL genes of varicella zoster virus in six provinces of China].
Mou JJ; Qi MY; Li CS; Zheng HY; Chen M; Zhou JH; He JL; Xu WW; Xu ST; Xu XG
Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):419-423. PubMed ID: 29614611
[No Abstract] [Full Text] [Related]
5. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.
Gomi Y; Sunamachi H; Mori Y; Nagaike K; Takahashi M; Yamanishi K
J Virol; 2002 Nov; 76(22):11447-59. PubMed ID: 12388706
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
Wu Q; Rivailler P; Xu S; Xu W
J Virol; 2019 May; 93(9):. PubMed ID: 30728261
[TBL] [Abstract][Full Text] [Related]
7. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.
Cohrs RJ; Gilden DH; Gomi Y; Yamanishi K; Cohen JI
J Virol; 2006 Mar; 80(5):2076-82. PubMed ID: 16474115
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
9. Genotyping of different varicella vaccine strains.
Sauerbrei A; Zell R; Harder M; Wutzler P
J Clin Virol; 2006 Oct; 37(2):109-17. PubMed ID: 16905356
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Quinlivan M; Gershon AA; Steinberg SP; Breuer J
J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
[TBL] [Abstract][Full Text] [Related]
12. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
13. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses.
Gomi Y; Imagawa T; Takahashi M; Yamanishi K
Arch Virol Suppl; 2001; (17):49-56. PubMed ID: 11339550
[TBL] [Abstract][Full Text] [Related]
14. Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms.
Depledge DP; Yamanishi K; Gomi Y; Gershon AA; Breuer J
J Virol; 2016 Oct; 90(19):8698-704. PubMed ID: 27440875
[TBL] [Abstract][Full Text] [Related]
15. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity.
Gomi Y; Imagawa T; Takahashi M; Yamanishi K
J Med Virol; 2000 Aug; 61(4):497-503. PubMed ID: 10897069
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.
Thiele S; Borschewski A; Küchler J; Bieberbach M; Voigt S; Ehlers B
Clin Vaccine Immunol; 2011 Jul; 18(7):1058-66. PubMed ID: 21562115
[TBL] [Abstract][Full Text] [Related]
17. Vaccine-type mutations identified in Varicella zoster virus passaged in cell culture.
Kim SC; Won YH; Park JS; Jeon JS; Ahn JH; Song MJ; Shin OS; Lee CH
Virus Res; 2018 Feb; 245():62-68. PubMed ID: 29242077
[TBL] [Abstract][Full Text] [Related]
18. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
19. Assessment of attenuation of varicella-zoster virus vaccines based on genomic comparison.
Moon JY; Seo J; Lee J; Park D
J Med Virol; 2023 Mar; 95(3):e28590. PubMed ID: 36807919
[TBL] [Abstract][Full Text] [Related]
20. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
